SCHEMBL9610044

SCHEMBL9610044

NNC(=O)c1ccc(NNC=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 2/20 0.52
CYP3A4 P08684 2/20 0.52
GFER P55789 2/20 0.52
KDM5A P29375 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
HIF1A Q16665 1/20 0.52
ALDH1A1 P00352 6/20 0.50
MAPT P10636 5/20 0.50
KDM4E B2RXH2 5/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
LMNA P02545 2/20 0.50
OGG1 O15527 1/20 0.50
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 1/20 0.46
CYP1A2 P05177 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2A6 P11509 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4795623 0.81 ALDH1A1 (0.44) CYP3A4BLMPMP22ALDH1A1MAPT
SCHEMBL343630 0.77 MPO (0.80) MPOCYP3A4GFERKDM5ABLM
SCHEMBL2678949 0.77 MPO (0.80) MPOCYP3A4GFERKDM5ABLM
SCHEMBL27895985 0.76 RAB9A (0.71) CYP3A4ALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL19607546 0.76 MPO (0.64) MPOCYP3A4GFERKDM5ABLM
SCHEMBL6469729 0.76 MPO (0.64) MPOCYP3A4GFERKDM5ABLM
SCHEMBL11541280 0.76 GFER (0.59) MPOCYP3A4GFERKDM5ABLM
SCHEMBL28188923 0.75 MPO (0.76) MPOCYP3A4GFERKDM5ABLM
SCHEMBL8292215 0.74 MPO (0.61) MPOCYP3A4GFERKDM5ABLM
Hydrochloric Acid SCHEMBL28169553 0.74 MPO (0.61) MPOCYP3A4GFERKDM5ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169208-B2 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties E I DU PONT DE NEMOURS AND COMPANY (US) 2015-10-27 US disclosed
US-20120135249-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-05-31 US disclosed
US-20110024691-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135249-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES AHR, TYR, ARNT MPO 1625/4885CYP3A4 117/4885GFER 2272/4885
US-20110024691-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES AHR, TYR, ARNT MPO 1625/4885CYP3A4 117/4885GFER 2272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.